Managers / Q4 2018 · view latest →
Biondo Investment Advisors, LLC
CIK 0001455176 · 540 ROUTE 6 & 209, P.O. BOX 909, MILFORD, PA, 18337 · 570-296-5525
Summary
Biondo Investment Advisors, LLC reported $331M in U.S.-listed holdings across 79 positions for Q4 2018.
Its largest position, ISRG, represents 9.9% of the portfolio.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 90.2% · $299M
- ETP · 6.6% · $22M
- Other · 2.3% · $8M
- ADR · 0.7% · $2M
- MLP · 0.2% · $510,000
- Other · 0.1% · $323,000
Quarter-over-Quarter Changes full breakdown →
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| ISRGINTUITIVE SURGICAL INC | NEW | +68.5K | 68.5K | +$33M | $33M |
| MAMASTERCARD INCORPORATED | NEW | +155.7K | 155.7K | +$29M | $29M |
| ABMDEURABIOMED INC | NEW | +65.6K | 65.6K | +$21M | $21M |
| AAPLAPPLE INC | NEW | +128.5K | 128.5K | +$20M | $20M |
| ILMNILLUMINA INC | NEW | +51.6K | 51.6K | +$15M | $15M |
| GOOGLALPHABET INC CAP STK | NEW | +12.2K | 12.2K | +$13M | $13M |
| IDXXIDEXX LABS INC | NEW | +64.5K | 64.5K | +$12M | $12M |
| EXKEXACT SCIENCES CORP | NEW | +159.3K | 159.3K | +$10M | $10M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2018
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $780M | 82 | May 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $827M | 86 | Feb 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $799M | 88 | Nov 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $759M | 89 | Aug 8, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $705M | 85 | May 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $726M | 90 | Feb 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $730M | 92 | Nov 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $676M | 89 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $647M | 90 | May 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $588M | 84 | Feb 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $531M | 78 | Nov 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $541M | 75 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $495M | 76 | May 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $449M | 73 | Feb 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $434M | 74 | Nov 7, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $454M | 76 | Aug 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $568M | 79 | May 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $600M | 82 | Feb 8, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $583M | 85 | Nov 9, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $582M | 85 | Aug 3, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $502M | 81 | May 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $522M | 85 | Feb 4, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $461M | 83 | Nov 5, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $396M | 77 | Aug 7, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $302M | 70 | May 8, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $433M | 87 | Feb 6, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $391M | 86 | Nov 5, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $422M | 88 | Aug 6, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $399M | 81 | May 8, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $331M | 79 | Feb 8, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.